BTB Real Estate Investment Trust (TSX: BTB.UN) (“BTB” or the “REIT”) announced today that the monthly cash distribution for the month of October 2024 is $0.025 per unit, representing $0.30 per unit on an annualized basis. The cash distribution will be paid on November 15th, 2024, to unitholders of record on October 31st, 2024. AboutBTB […]
NAPLES, Fla., Oct. 15, 2024 (GLOBE NEWSWIRE) — via IBN — HealthLynked Corp. (OTCQB: HLYK), a leader in connecting patients, doctors, and healthcare data, announced the filing of its non-provisional patent this past week with the United States Patent and Trademark Office (USPTO) for ARi, an innovative artificial intelligence (AI)-powered personal healthcare assistant. This filing
Nashville, TN, Oct. 15, 2024 (GLOBE NEWSWIRE) — American Rebel Holdings, Inc. (NASDAQ: AREB) (“American Rebel” or the “Company”), America’s Patriotic Brand and the creator of American Rebel Beer (www.americanrebelbeer.com), and branded safes, personal security and self-defense products and apparel, today announced American Rebel Beer’s Connecticut launch party at the legendary Toad’s Place in New
Arvada, CO, USA, Oct. 15, 2024 (GLOBE NEWSWIRE) — Wellspring, the world’s leading provider of Tech Transfer, Intellectual Property Management, and Innovation Management software solutions, today announced significant leadership appointments following its recent acquisition of Sopheon, a major player in enterprise innovation management solutions. These strategic hires are set to enhance Wellspring’s position as a
Carlsbad, CA, Oct. 15, 2024 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade,” “Palisade Bio” or the “Company”), a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune, inflammatory, and fibrotic diseases, today announced that its abstract has been accepted for poster presentation at ACG’s 2024 Annual Scientific Meeting being
NEW YORK, Oct. 15, 2024 (GLOBE NEWSWIRE) — Indaptus Therapeutics, Inc. (Nasdaq: INDP) (“Indaptus” or the “Company”), a clinical stage biotechnology company dedicated to pioneering innovative cancer and viral infection treatments, provides an update regarding key clinical advancements in its Phase 1 trial of lead drug candidate Decoy20. The Safety Review Committee examined weekly administration
NEWARK, Calif., Oct. 15, 2024 (GLOBE NEWSWIRE) — Concentrix Corporation (NASDAQ: CNXC), a global technology and services leader, announced today that leading research firm Everest Group has positioned the company as a Leader in its Europe, Middle East and Africa (EMEA) Customer Experience Management (CXM) Services PEAK Matrix(R) Assessment 2024. For the third consecutive year,
BOSTON and LONDON, Oct. 15, 2024 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), an innovative biotechnology company developing advanced therapies for autoimmune and inflammatory diseases, announces the effectiveness of the Form S-4, originally filed with the SEC on September 13, 2024 related to the merger of Akari Therapeutics, Plc (the Company) and Peak Bio,
SAN DIEGO, Oct. 15, 2024 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX) (“Ventyx”), a clinical-stage biopharmaceutical company focused on advancing novel oral therapies that address a broad range of inflammatory diseases with significant unmet medical need, today announced that a late-breaking abstract including new long-term extension (LTE) data from the Phase 2 trial of
ROCKY MOUNT, N.C., Oct. 15, 2024 (GLOBE NEWSWIRE) — Hardee’s franchise owner-operator, Boddie-Noell Enterprises, recently raised more than $17,000 for the Navy SEAL Foundation (NSF) to support the Naval Special Warfare (NSW) community. The fundraiser, held at Harrisonburg, Richmond, and Washington, D.C. area Hardee’s, was part of a limited-time FRYDAY promotion in which twenty-five cents